Altshuler Shaham’s Immunic IMUX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-2,220
Closed -$77K 495
2022
Q2
$77K Hold
2,220
﹤0.01% 186
2022
Q1
$251K Sell
2,220
-1,100
-33% -$127K ﹤0.01% 195
2021
Q4
$318K Hold
3,320
﹤0.01% 216
2021
Q3
$295K Hold
3,320
﹤0.01% 225
2021
Q2
$407K Hold
3,320
﹤0.01% 223
2021
Q1
$529K Hold
3,320
0.01% 120
2020
Q4
$508K Buy
+3,320
New +$596K 0.01% 106

Other funds holding IMUX

Altshuler Shaham's IMUX Position: Q3 2022 in Review

Altshuler Shaham sold out of Immunic (IMUX) in Q3 2022, closing a stake of 2,220 shares — an estimated $77K sold.

Altshuler Shaham first reported a position in IMUX in Q4 2020 and held it in 7 quarters. The position peaked at $529K in Q1 2021. 65 funds tracked by Wall St. Rank hold IMUX as of Q3 2022.

  • Altshuler Shaham reported no remaining Immunic position as of Q3 2022 after selling out during the quarter.
  • Altshuler Shaham sold 2,220 Immunic shares in Q3 2022, an estimated $77K.
  • Altshuler Shaham first reported a position in Immunic in Q4 2020 and held it in 7 quarters.
  • Altshuler Shaham's Immunic position peaked at $529K in Q1 2021.
  • 65 funds tracked by Wall St. Rank held Immunic as of Q3 2022.

Based on Altshuler Shaham's 13F filing for Q3 2022, filed 14 Nov 2022.